Bristol-Myers Squibb Co. said it will plead guilty to criminal charges to settle a U.S. antitrust case arising from a bungled patent settlement over the drugmaker's blood-thinner Plavix.
The New York-based company will admit to two counts of providing false statements to a government agency. The maximum fine for the charges is $1 million, the company said today.
Bristol-Myers said the false statements were made by ``a former Bristol-Myers Squibb senior executive.''
Bloomberg
No comments:
Post a Comment